by Bruce Sylvester: Researchers report that 90% of subjects with acute lymphoblastic leukemia (ALL) who had relapsed multiple times or failed to respond to standard therapies have achieved… read more.
by Bruce Sylvester – Compared to no screening, flexible sigmoidoscopy screening has resulted in a reduced incidence of colorectal cancer and rate of death from colorectal cancer, researchers… read more.
by Thomas R. Collins – After evaluating data on 5 million adults in the UK, researchers concluded that an increasing body mass index (BMI) raises the odds of… read more.
by Bruce Sylvester – Ibrutinib has significantly outperformed ofatumumab as a second-line therapy for chronic lymphocytic leukemia (CLL), according to a Phase 3 study published on May 31,… read more.
World Congress on Gastrointestinal Cancer (WCGC) meeting, Barcelona 25 – 28 June 2014.
What we are doing now, what the future Holds, and how Tumour profiling is just the beginning by Dr Paul Ross, Guy’s & St Thomas’ Hospitals, London. At… read more.
by Bruce Sylvester – Ibrutinib has significantly outperformed ofatumumab as a second-line therapy for chronic lymphocytic leukemia (CLL), according to a Phase 3 study published on May 31,… read more.
by Bruce Sylvester: Fenofibrate treatment reduces cardiovascular disease risks in persons with type-2 diabetes, especially women, researchers reported on August 18 in Diabetologia.
by Bruce Sylvester: Rapamycin appears to shrink one type of pancreatic cancer tumor and prevents it from spreading, researchers reported on August 3, 2014 in the journal Gut.
by Bruce Sylvester: In spite of preclinical signs of preventing tumor progression and improving survival, everolimus does not improve overall survival in patients with advanced liver cancer when… read more.
German and UK citizens make up bulk of numbers; neurological diseases most common reason to end life. Citizens from Germany and the UK make up the bulk of… read more.
German and UK citizens make up bulk of numbers; neurological diseases most common reason to end life. Citizens from Germany and the UK make up the bulk of… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
